UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Decreased by CIBC Private Wealth Group LLC

CIBC Private Wealth Group LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 1,438,738 shares of the healthcare conglomerate’s stock after selling 43,985 shares during the quarter. UnitedHealth Group makes up about 1.4% of CIBC Private Wealth Group LLC’s investment portfolio, making the stock its 11th largest position. CIBC Private Wealth Group LLC’s holdings in UnitedHealth Group were worth $754,647,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $32,000. Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $40,000. Finally, Legacy Investment Solutions LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on UNH shares. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Down 0.0 %

Shares of UNH opened at $515.47 on Friday. The business’s 50 day simple moving average is $508.81 and its 200-day simple moving average is $544.24. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $471.51 billion, a P/E ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.